Published in Mol Cell Biol on May 01, 2000
Redundancy, antiredundancy, and the robustness of genomes. Proc Natl Acad Sci U S A (2002) 2.42
Site-specific incorporation of an unnatural amino acid into proteins in mammalian cells. Nucleic Acids Res (2002) 1.64
Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet (2014) 1.23
Functional analysis of human tRNA isodecoders. J Mol Biol (2009) 1.13
Import of amber and ochre suppressor tRNAs into mammalian cells: a general approach to site-specific insertion of amino acid analogues into proteins. Proc Natl Acad Sci U S A (2001) 1.11
Stop codon suppression via inhibition of eRF1 expression. RNA (2003) 0.87
The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through. Neurobiol Dis (2012) 0.85
Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse. PLoS One (2007) 0.81
Enhanced detection of tRNA isoacceptors by combinatorial oligonucleotide hybridization. RNA (2000) 0.81
Genetic code expansion in the mouse brain. Nat Chem Biol (2016) 0.80
Ex vivo correction of selenoprotein N deficiency in rigid spine muscular dystrophy caused by a mutation in the selenocysteine codon. Nucleic Acids Res (2007) 0.77
A dual fluorescent reporter for the investigation of methionine mistranslation in live cells. RNA (2016) 0.77
Control of gene expression through the nonsense-mediated RNA decay pathway. Cell Biosci (2017) 0.75
Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. Eur J Hum Genet (2014) 0.75
Direct gene transfer into mouse muscle in vivo. Science (1990) 10.39
Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med (1988) 5.84
Direct analysis of aminoacylation levels of tRNAs in vivo. Application to studying recognition of Escherichia coli initiator tRNA mutants by glutaminyl-tRNA synthetase. J Biol Chem (1991) 5.02
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol (1986) 3.61
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med (1999) 3.39
Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest (1999) 3.06
The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J Mol Biol (1995) 2.97
Construction of a functional human suppressor tRNA gene: an approach to gene therapy for beta-thalassaemia. Nature (1982) 2.65
Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. N Engl J Med (1990) 2.37
An inducible mammalian amber suppressor: propagation of a poliovirus mutant. Cell (1987) 2.08
Emerging understanding of translation termination. Cell (1996) 2.02
Transcription occurs in pulses in muscle fibers. Genes Dev (1998) 1.77
Establishment of mammalian cell lines containing multiple nonsense mutations and functional suppressor tRNA genes. Cell (1982) 1.76
Localization of muscle gene products in nuclear domains. Nature (1989) 1.75
Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum Gene Ther (1993) 1.73
Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A (1993) 1.72
Amber, ochre and opal suppressor tRNA genes derived from a human serine tRNA gene. EMBO J (1985) 1.68
Introduction of UAG, UAA, and UGA nonsense mutations at a specific site in the Escherichia coli chloramphenicol acetyltransferase gene: use in measurement of amber, ochre, and opal suppression in mammalian cells. Mol Cell Biol (1986) 1.60
Structure of the C-terminal end of the nascent peptide influences translation termination. EMBO J (1996) 1.60
Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med (1996) 1.54
The nucleotide sequence of a human serine tRNA gene. Nucleic Acids Res (1987) 1.46
Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques (1991) 1.46
The influence of 5' codon context on translation termination in Saccharomyces cerevisiae. Eur J Biochem (1998) 1.46
Distribution of both lengths and 5' terminal nucleotides of mammalian pre-tRNA 3' trailers reflects properties of 3' processing endoribonuclease. Nucleic Acids Res (1997) 1.45
Transfer of a protein encoded by a single nucleus to nearby nuclei in multinucleated myotubes. Science (1989) 1.44
Isopentenyladenosine deficient tRNA from an antisuppressor mutant of Saccharomyces cerevisiae. Nucleic Acids Res (1978) 1.43
Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther (1996) 1.34
Amber suppression in mammalian cells dependent upon expression of an Escherichia coli aminoacyl-tRNA synthetase gene. Mol Cell Biol (1996) 1.29
Identity determinants of human tRNA(Ser): sequence elements necessary for serylation and maturation of a tRNA with a long extra arm. EMBO J (1993) 1.27
Context effects on misreading and suppression at UAG codons in human cells. Mol Cell Biol (1995) 1.22
Effect of the higher-order structure of tRNAs on the stability of hybrids with oligodeoxyribonucleotides: separation of tRNA by an efficient solution hybridization. Nucleic Acids Res (1992) 1.19
Establishment of a system for conditional gene expression using an inducible tRNA suppressor gene. Mol Cell Biol (1992) 1.11
The antisuppressor strain sin1 of Schizosaccharomyces pombe lacks the modification isopentenyladenosine in transfer RNA. J Mol Biol (1980) 1.11
Mutations to nonsense codons in human genetic disease: implications for gene therapy by nonsense suppressor tRNAs. Nucleic Acids Res (1994) 1.10
Sequence specificity of tRNA-modifying enzymes. An analysis of 258 tRNA sequences. Biochim Biophys Acta (1983) 1.08
Construction, stable transformation, and function of an amber suppressor tRNA gene in Drosophila melanogaster. Proc Natl Acad Sci U S A (1989) 1.04
Identification of an amber nonsense mutation in the rosy516 gene by germline transformation of an amber suppressor tRNA gene. EMBO J (1988) 1.01
Usage of the three termination codons in a single eukaryotic cell, the Xenopus laevis oocyte. Nucleic Acids Res (1981) 0.96
Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther (1994) 0.93
Limited diffusibility of gene products directed by a single nucleus in the cytoplasm of multinucleated myofibres. FEBS Lett (1994) 0.91
Direct gene transfer into the mouse heart. J Mol Cell Cardiol (1997) 0.89
Regulated expression of a mammalian nonsense suppressor tRNA gene in vivo and in vitro using the lac operator/repressor system. Mol Cell Biol (1992) 0.88
Tetracycline-regulated suppression of amber codons in mammalian cells. Mol Cell Biol (1998) 0.87
A developmental study of the abnormal expression of alpha-cardiac and alpha-skeletal actins in the striated muscle of a mutant mouse. Dev Biol (1989) 0.86
Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA. Hum Gene Ther (1999) 0.83
Lack of a specific ribose methylation at guanosine 17 in Morris hepatoma 5123D tRNASer1IGA. Cancer Res (1981) 0.83
Modulation of the phenotypic expression of a human serine tRNA gene by 5'-flanking sequences. DNA (1988) 0.82
Direct DNA injection into mouse tongue muscle for analysis of promoter function in vivo. Somat Cell Mol Genet (1993) 0.81
Regulated expression of plant tRNA genes by the prokaryotic tet and lac repressors. Plant Mol Biol (1997) 0.79
Retracted Ochre suppressor transfer RNA restored dystrophin expression in mdx mice. Life Sci (1997) 0.78
Using mini-prep plasmid DNA for sequencing double stranded templates with Sequenase. Biotechniques (1988) 10.14
Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res (2000) 3.08
Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc Natl Acad Sci U S A (1984) 2.64
Myosin heavy chain gene expression in human heart failure. J Clin Invest (1997) 2.39
Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol (1985) (2001) 2.24
Human cardiac myosin heavy chain genes and their linkage in the genome. Nucleic Acids Res (1987) 2.22
The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol (1996) 2.20
Conserved protein domains in a myosin heavy chain gene from Dictyostelium discoideum. Proc Natl Acad Sci U S A (1986) 2.05
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest (1999) 1.95
Functional analysis of human cardiac gap junction channel mutants. Proc Natl Acad Sci U S A (1991) 1.94
Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res (1995) 1.91
The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther (1994) 1.82
Molecular characterization and functional expression of the human cardiac gap junction channel. J Cell Biol (1990) 1.81
Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem (1994) 1.77
A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.77
Multigene family for sarcomeric myosin heavy chain in mouse and human DNA: localization on a single chromosome. Science (1983) 1.74
Isolation and characterization of human myosin heavy chain genes. Proc Natl Acad Sci U S A (1983) 1.72
Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A (1993) 1.72
Cloning and characterization of a nonmuscle myosin heavy chain cDNA. Proc Natl Acad Sci U S A (1985) 1.69
Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol (2000) 1.60
Contractile protein mutations and heart disease. Curr Opin Cell Biol (1996) 1.58
Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med (1996) 1.54
A 29 residue region of the sarcomeric myosin rod is necessary for filament formation. J Mol Biol (1997) 1.52
Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity. J Mol Biol (1999) 1.52
Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. J Mol Biol (1989) 1.46
Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res (1998) 1.44
Three slow myosin heavy chains sequentially expressed in developing mammalian skeletal muscle. Dev Biol (1993) 1.40
Different pathways regulate expression of the skeletal myosin heavy chain genes. J Biol Chem (2001) 1.38
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest (2001) 1.37
Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am J Physiol Heart Circ Physiol (2001) 1.36
Mapping class I gene sequences in the major histocompatibility complex. Nature (1982) 1.35
Characterization of diverse forms of myosin heavy chain expressed in adult human skeletal muscle. Nucleic Acids Res (1986) 1.34
Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci U S A (1991) 1.31
Human nonmuscle myosin heavy chain mRNA: generation of diversity through alternative polyadenylylation. Proc Natl Acad Sci U S A (1990) 1.30
Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. J Mol Cell Cardiol (1989) 1.18
Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy. Am J Physiol Cell Physiol (2001) 1.18
Sarcomeric gene expression and contractility in myofibroblasts. J Cell Biol (1997) 1.15
Myosin heavy chains IIa and IId are functionally distinct in the mouse. J Cell Biol (1998) 1.14
Thyroid hormone regulates expression of a transfected human alpha-myosin heavy-chain fusion gene in fetal rat heart cells. Proc Natl Acad Sci U S A (1990) 1.14
Cardiac adaptations to chronic exercise in mice. Am J Physiol (1994) 1.13
Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cardiol (1994) 1.12
Assignment of the gene governing cellular ouabain resistance to Mus musculus chromosome 3 using human/mouse microcell hybrids. Biochem Genet (1979) 1.12
Expression in Escherichia coli of a functional Dictyostelium myosin tail fragment. J Cell Biol (1987) 1.11
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. Am J Physiol Heart Circ Physiol (2001) 1.10
Sequence of the complete P protein gene and part of the M protein gene from the histidine transport operon of Escherichia coli compared to that of Salmonella typhimurium. Nucleic Acids Res (1987) 1.09
Behavior of genes directly injected into the rat heart in vivo. Circ Res (1992) 1.08
Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains. Dev Biol (2001) 1.08
Regulation of growth and differentiation of a rat hepatoma cell line by the synergistic interactions of hormones and collagenous substrata. J Cell Biol (1983) 1.07
Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. Dev Biol (1999) 1.07
Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. J Appl Physiol (1985) (2002) 1.05
Distinct behavior of cardiac myosin heavy chain gene constructs in vivo. Discordance with in vitro results. Circ Res (1993) 1.04
Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. Biophys J (1998) 1.04
Skeletal muscle adaptations to microgravity exposure in the mouse. J Appl Physiol (1985) (2003) 1.03
The human connexin gene family of gap junction proteins: distinct chromosomal locations but similar structures. Genomics (1991) 1.03
Modulation of myosin filament organization by C-protein family members. Mol Biol Cell (1996) 1.02
Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene. Nucleic Acids Res (1989) 1.02
Fast myosin heavy chains expressed in secondary mammalian muscle fibers at the time of their inception. J Cell Sci (1994) 1.01
Myofibroblasts: molecular crossdressers. Curr Top Dev Biol (2001) 1.01
Expression of connexin43 in the developing rat heart. Circ Res (1991) 1.00
Regulation of scallop myosin by mutant regulatory light chains. J Mol Biol (1990) 1.00
Animal models of hypertrophic cardiomyopathy. Curr Opin Cardiol (2000) 0.98
A highly conserved mouse gene with a propensity to form pseudogenes in mammals. Mol Cell Biol (1988) 0.97
Molecular genetic characterization of a developmentally regulated human perinatal myosin heavy chain. J Cell Biol (1989) 0.96
Cardiomyopathy in transgenic myf5 mice. Circ Res (1996) 0.95
Inactivation of myosin heavy chain genes in the mouse: diverse and unexpected phenotypes. Microsc Res Tech (2000) 0.94
Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload. J Clin Invest (1997) 0.93
Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A (1994) 0.93
Small RNA molecules related to the Alu family of repetitive DNA sequences. Mol Cell Biol (1982) 0.93
Sarcomeric myosin heavy chain expressed in nonmuscle cells forms thick filaments in the presence of substoichiometric amounts of light chains. Cell Motil Cytoskeleton (1993) 0.91
Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2001) 0.91
Assignment of the genes for triose phosphate isomerase to chromosome 6 and tripeptidase-1 to chromosome 10 in Mus musculus by somatic cell hybridization. Somatic Cell Genet (1978) 0.91
Complete nucleotide sequence of full length cDNA for rat alpha cardiac myosin heavy chain. Nucleic Acids Res (1989) 0.91
Ventricular myosin light chain 1 is developmentally regulated and does not change in hypertension. Nucleic Acids Res (1989) 0.90
Coexpression and assembly of myosin heavy chain and myosin light chain in Escherichia coli. Proc Natl Acad Sci U S A (1988) 0.90
Direct gene transfer into the mouse heart. J Mol Cell Cardiol (1997) 0.89
Identification of sequences necessary for the association of cardiac myosin subunits. J Cell Biol (1991) 0.88
Post-transcriptional regulation of rat alpha cardiac myosin heavy chain gene expression. J Biol Chem (1994) 0.87
Generation of a full-length human perinatal myosin heavy-chain-encoding cDNA. Gene (1990) 0.87
Gated magnetic resonance imaging of normal and hypertrophied murine hearts. Am J Physiol (1997) 0.87
Potential limitations of transcription terminators used as transgene insulators in adenoviral vectors. Gene Ther (2002) 0.86
Complete nucleotide sequence of full length cDNA for rat beta cardiac myosin heavy chain. Nucleic Acids Res (1989) 0.86
Cloning and characterization of the scallop essential and regulatory myosin light chain cDNAs. J Biol Chem (1987) 0.85
Cardiac myosin heavy chains lacking the light chain binding domain cause hypertrophic cardiomyopathy in mice. Am J Physiol (1999) 0.85
Rat liver fat-storing cell lines express sarcomeric myosin heavy chain mRNA and protein. Cell Motil Cytoskeleton (1993) 0.85
Complete cDNA sequence of rat atrial myosin light chain 1: patterns of expression during development and with hypertension. Nucleic Acids Res (1990) 0.84
Discordance between gene regulation in vitro and in vivo. Gene Expr (1992) 0.84
From sarcomeric mutations to heart disease: understanding familial hypertrophic cardiomyopathy. Cold Spring Harb Symp Quant Biol (2002) 0.84
Enhanced detection of tRNA isoacceptors by combinatorial oligonucleotide hybridization. RNA (2000) 0.81
Low sequence variation in the gene encoding the human beta-myosin heavy chain. Genomics (2001) 0.81
Functional analysis of a cardiac myosin rod in Dictyostelium discoideum. Cell Motil Cytoskeleton (1994) 0.80
Sequence organization of variant mouse 4.5 S RNA genes and pseudogenes. Genomics (1992) 0.80
Myoblast therapy. Science (1992) 0.79
A murine model for hypertrophic cardiomyopathy. Z Kardiol (1995) 0.79
The vertebrate myosin heavy chain: genetics and assembly properties. Cell Struct Funct (1997) 0.78
Repetitive nucleotide sequence insertions into a novel calmodulin-related gene and its processed pseudogene. Gene (1988) 0.78
Diversity of myosin-based motility: multiple genes and functions. Soc Gen Physiol Ser (1994) 0.78
Prospects for gene therapy with direct injection of polynucleotides. Ann N Y Acad Sci (1995) 0.77
Modulation of vascular endothelial gene expression by physical training in patients with chronic heart failure. Ital Heart J (2000) 0.76
A role for calreticulin in the adult heart? J Clin Invest (2001) 0.75